Zoetis EVP reports RSU vesting and tax share sale

Zoetis Inc. Executive Vice President Julie Fuller reported equity award activity tied to restricted stock units (RSUs).

Rhea-AI Filing Summary

Zoetis Inc. Executive Vice President Julie Fuller reported equity award activity tied to restricted stock units (RSUs). On February 19, 2026, RSUs converted into 750 shares of common stock at a stated price of $0.0000 per share, reflecting vesting and settlement of RSUs. On the same date, 290 common shares were disposed of at $127.2800 per share to cover tax obligations through a tax-withholding disposition. Footnotes explain that each RSU represents a right to receive one Zoetis common share, with one-third of each RSU grant generally vesting on each of the first, second, and third anniversaries of the grant dates, subject to continued service and certain earlier vesting events.

Insider Trade Summary

750.4257 shares exercised/converted

Exercise 5 txns

Insider FULLER JULIE

Role Executive Vice President

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	750.4257	$0.00	$0.00
Exercise	Common Stock	750	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	290	$127.28	$37K
holding	Restricted Stock Unit	--	--	--
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 6,706.2077 contracts for 5,206.2077 underlying shares (Direct); Common Stock — 1,063 shares (Direct)

Footnotes (7)

1. F1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
2. F2. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
3. F3. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
4. F4. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
5. F5. Not applicable.
6. F6. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. F7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, September 30, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Zoetis (ZTS) report for Executive Vice President Julie Fuller?

Zoetis reported that Executive Vice President Julie Fuller acquired 750 shares of common stock upon vesting of restricted stock units and disposed of 290 shares to cover tax liabilities. These transactions reflect scheduled equity award vesting rather than open-market purchases or sales.

How many Zoetis (ZTS) shares did Julie Fuller receive from RSU vesting?

Julie Fuller received 750 shares of Zoetis common stock when restricted stock units vested and settled on February 19, 2026. Each RSU represents a right to receive one share of common stock upon vesting, according to the footnote disclosures in the filing.

Why were 290 Zoetis (ZTS) shares disposed of in Julie Fuller’s Form 4 filing?

The filing states that 290 shares of Zoetis common stock were disposed of at $127.2800 per share to satisfy tax obligations. This is characterized as a tax-withholding disposition, where shares are delivered to cover taxes due on the vesting of equity awards.

What do the Zoetis (ZTS) RSU footnotes say about vesting for Julie Fuller’s awards?

The footnotes explain that one-third of each RSU grant generally vests and settles in Zoetis common stock on the first, second, and third anniversaries of the grant date, subject to continued service and possible earlier vesting upon specified events.

What equity plan governs Julie Fuller’s restricted stock units at Zoetis (ZTS)?

The restricted stock units are granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. Footnotes note that RSUs include both original grants and dividend equivalent units, each representing a right to receive one share upon vesting.

Are Julie Fuller’s Zoetis (ZTS) transactions open-market buys or sells?

The transactions are not open-market buys or sells. The Form 4 describes them as an exercise or conversion of derivative securities into common stock and a tax-withholding disposition to pay tax liabilities tied to the vesting of restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FULLER JULIE

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		M		750	A	(1)	1,353	D
Common Stock	02/19/2026		F		290	D	$127.28	1,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(2)	(3)	02/19/2026		M			750.4257	(4)	(5)	Common Stock	750.4257	(1)	1,500	D
Restricted Stock Unit(2)	(3)							(6)	(5)	Common Stock	3,626		3,626	D
Restricted Stock Unit(2)	(3)							(7)	(5)	Common Stock	1,580.2077		1,580.2077	D

Explanation of Responses:

1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

2. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

3. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

4. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

5. Not applicable.

6. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, September 30, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.